Skip to main content
Clinical Trials/IRCT201507069045N3
IRCT201507069045N3
Completed
Phase 2

Role of early hemodialysis on acute kidney injury in critically ill patients at Tehran Imam Khomeini Hospital

Vice Chancellor for research , Tehran University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Acute renal injury.
Sponsor
Vice Chancellor for research , Tehran University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for research , Tehran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • if there is one of the following scales such as ; at least 50% creatinine rise from the admission time ; BUN\>70 ; oliguria \<0\.5 ml/kg/h for 12 hours with no response to volume and Furosemide ; anuria \<0\.3 ml/kg/h for 6 hours with no response to volume and Furosemide; will be specified as Early Hemodialysis Group (D) and if there is criteria such as volume overload ( pulmonary edema) ; BUN\>100 or occurance of azotemia complications ( ex:loss of Consciousness ) and cr\>4 will be specified as Group C. In case of oliguria (U/O\<0\.5 ml/kg/h) or aniria (U/O\<0\.3 ml/kg/h or cessation of urine ) , infusion of 500 ml crystalloid with 60 mg Furosemide in 1 hour will be administered and while there is no response , the patient entered the study; Exclusion criteria: history of renal insufficiency ; reception of high dose inotropics; septic shock ; severe electrolyte abnormalities leading to hemodialysis.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials